---
schema_version: "secwatch.filing_event.v1"
accession: "0001091818-26-000140"
form_type: "8-K"
ticker: "BFNH"
cik: "0001310488"
company_name: "BIOFORCE NANOSCIENCES HOLDINGS, INC."
filed_at: "2026-09-04T16:51:02+00:00"
generated_at: "2026-09-04T16:52:20.322813+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioForce issues 4.5M restricted shares for $2.48M in services

## Summary
- On Aug 31, 2026, issued 4,516,909 restricted common shares for services valued at $2,484,300.
- Shares sold in private placement under Section 4(2); no commissions or fees paid.
- Purchasers represent investment intent; shares carry Rule 144 restrictive legend.
- CEO/CFO Richard Kaiser signed filing; company is an emerging growth company.

## SEC filing metadata
- accession: 0001091818-26-000140
- form_type: 8-K
- ticker: BFNH
- cik: 0001310488
- company_name: BIOFORCE NANOSCIENCES HOLDINGS, INC.
- filed_at: 2026-09-04T16:51:02+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1310488/000109181826000140/0001091818-26-000140-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1310488/000109181826000140/bfnh-09042026_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001091818-26-000140
- JSON: https://secwatch.observer/filing/0001091818-26-000140.json
- Plain text: https://secwatch.observer/filing/0001091818-26-000140.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.